Edition:
United States

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

26.80USD
1:33pm EDT
Change (% chg)

$-0.20 (-0.74%)
Prev Close
$27.00
Open
$26.92
Day's High
$26.93
Day's Low
$26.62
Volume
24,726
Avg. Vol
148,212
52-wk High
$29.99
52-wk Low
$13.91

NXTM.OQ

Chart for NXTM.OQ

About

NxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services... (more)

Overall

Beta: 0.38
Market Cap(Mil.): $1,760.84
Shares Outstanding(Mil.): 65.22
Dividend: --
Yield (%): --

Financials

  NXTM.OQ Industry Sector
P/E (TTM): -- 48.04 29.98
EPS (TTM): -0.07 -- --
ROI: -2.76 6.89 13.08
ROE: -2.43 10.85 14.23

BRIEF-NxStage Medical announces CE mark for its NxGen Hemodialysis System

* Nxstage medical announces ce mark for its nxgen hemodialysis system Source text for Eikon: Further company coverage:

Mar 02 2017

BRIEF-NxStage reports Q4 revenue of $93 million

* NxStage reports fourth quarter and full-year 2016 financial results

Feb 28 2017

BRIEF-NxStage reports Q3 revenue $92 mln

* Says for fy company now expects revenue to be at high end of its previously increased guidance range of $360 to $365 million

Nov 03 2016

More From Around the Web

Competitors

Earnings vs. Estimates